These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 19705871)

  • 21. Synthesis, anticonvulsant activity and 5-HT1A, 5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione.
    Obniska J; Kołaczkowski M; Bojarski AJ; Duszyńska B
    Eur J Med Chem; 2006 Jul; 41(7):874-81. PubMed ID: 16600439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands.
    Siracusa MA; Salerno L; Modica MN; Pittalà V; Romeo G; Amato ME; Nowak M; Bojarski AJ; Mereghetti I; Cagnotto A; Mennini T
    J Med Chem; 2008 Aug; 51(15):4529-38. PubMed ID: 18598015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of an ethylene spacer on the 5-HT(1A) and 5-HT(2A) receptor affinity of arylpiperazine derivatives of amides with N-acylated amino acids and 3-differently substituted pyrrolidine-2,5-diones.
    Zajdel P; Subra G; Verdie P; Bojarski AJ; Duszyńska B; Basista K; Obniska J; Martinez J; Pawłowski M
    Eur J Med Chem; 2009 Feb; 44(2):800-8. PubMed ID: 18603331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
    Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
    J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and structural investigation of some pyrimido[5,4-c]quinolin-4(3H)-one derivatives with a long-chain arylpiperazine moiety as potent 5-HT(1A/2A) and 5-HT(7) receptor ligands.
    Lewgowd W; Bojarski AJ; Szczesio M; Olczak A; Glowka ML; Mordalski S; Stanczak A
    Eur J Med Chem; 2011 Aug; 46(8):3348-61. PubMed ID: 21601317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of molecular probes for the human 5-HT(6) receptor.
    Vázquez-Villa H; González-Vera JA; Benhamú B; Viso A; Fernández de la Pradilla R; Junquera E; Aicart E; López-Rodríguez ML; Ortega-Gutiérrez S
    J Med Chem; 2010 Oct; 53(19):7095-106. PubMed ID: 20845907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of piperazine derivatives as 5-HT7 receptor antagonists.
    Yoon J; Yoo EA; Kim JY; Pae AN; Rhim H; Park WK; Kong JY; Park Choo HY
    Bioorg Med Chem; 2008 May; 16(10):5405-12. PubMed ID: 18456500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of new piperazine-pyridazinone derivatives and their binding affinity toward alpha1-, alpha2-adrenergic and 5-HT1A serotoninergic receptors.
    Betti L; Zanelli M; Giannaccini G; Manetti F; Schenone S; Strappaghetti G
    Bioorg Med Chem; 2006 Apr; 14(8):2828-36. PubMed ID: 16376083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part III.
    Herold F; Król M; Kleps J
    Acta Pol Pharm; 2004; 61(2):139-50. PubMed ID: 15493297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, in vitro and in vivo 5-HT1A/5-HT2A serotonin receptor activity of new hybrid 1,2,3,4-tetrahydro-gamma-carbolines with 1-(2-methoxyphenyl)piperazine moiety.
    Boksa J; Charakchieva-Minol S; Duszyńska B; Bugno R; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E; Bojarski AJ
    Pol J Pharmacol; 2003; 55(6):1013-9. PubMed ID: 14730096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-[omega-[4-arylpiperazin-1-yl]alkoxy]phenyl)imidazo[1,2-a]pyridine derivatives: fluorescent high-affinity dopamine D3 receptor ligands as potential probes for receptor visualization.
    Leopoldo M; Lacivita E; Passafiume E; Contino M; Colabufo NA; Berardi F; Perrone R
    J Med Chem; 2007 Oct; 50(20):5043-7. PubMed ID: 17850060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and structure-activity relationships of 1-aralkyl-4-benzylpiperidine and 1-aralkyl-4-benzylpiperazine derivatives as potent sigma ligands.
    Costantino L; Gandolfi F; Sorbi C; Franchini S; Prezzavento O; Vittorio F; Ronsisvalle G; Leonardi A; Poggesi E; Brasili L
    J Med Chem; 2005 Jan; 48(1):266-73. PubMed ID: 15634021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and structure-activity relationships of a new model of arylpiperazines. 8. Computational simulation of ligand-receptor interaction of 5-HT(1A)R agonists with selectivity over alpha1-adrenoceptors.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Benhamú B; Tejada I; Ayala D; Viso A; Campillo M; Pardo L; Delgado M; Manzanares J; Fuentes JA
    J Med Chem; 2005 Apr; 48(7):2548-58. PubMed ID: 15801844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-intrinsic activity relationship studies in the group of 1-imido/amido substituted 4-(4-arylpiperazin-1-yl)cyclohexane derivatives; new, potent 5-HT1A receptor agents with anxiolytic- like activity.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Bugno R; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2006 Mar; 14(5):1391-402. PubMed ID: 16266808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: synthesis and biological evaluation.
    Badarau E; Suzenet F; Bojarski AJ; Fînaru AL; Guillaumet G
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1600-3. PubMed ID: 19237285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands.
    Chu W; Tu Z; McElveen E; Xu J; Taylor M; Luedtke RR; Mach RH
    Bioorg Med Chem; 2005 Jan; 13(1):77-87. PubMed ID: 15582454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel benzofuran derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
    Venkatesan AM; Dos Santos O; Ellingboe J; Evrard DA; Harrison BL; Smith DL; Scerni R; Hornby GA; Schechter LE; Andree TH
    Bioorg Med Chem Lett; 2010 Feb; 20(3):824-7. PubMed ID: 20064720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and in-vitro pharmacological evaluation of new 5-HT1A receptor ligands containing a benzotriazinone nucleus.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Frecentese F; Massarelli P; Bruni G; Collavoli E; Santagada V; Caliendo G
    Arch Pharm (Weinheim); 2008 Jan; 341(1):20-7. PubMed ID: 18072244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane organization of the human serotonin(1A) receptor monitored by detergent insolubility using GFP fluorescence.
    Kalipatnapu S; Chattopadhyay A
    Mol Membr Biol; 2005; 22(6):539-47. PubMed ID: 16373325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors.
    Sorbi C; Franchini S; Tait A; Prandi A; Gallesi R; Angeli P; Marucci G; Pirona L; Poggesi E; Brasili L
    ChemMedChem; 2009 Mar; 4(3):393-9. PubMed ID: 19152363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.